alpha-glucosidase (Pharming)

N/A

Report date: 2025/01/26 18:34:47

Base Information

Drug Namealpha-glucosidase (Pharming)
Drug Alias Namealpha-glucosidasealpha-glucosidase (Pharming)Pompes disease therapy (Pharming)GD-halpha-GLU
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionAlpha-glucosidases modulators
TargetsAlpha-glucosidases
Therapy Area/IndicationsFabry DiseaseGlycogen Storage Disease Type IIMuscular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWestern EuropeNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharming Group Nv
China Registration ClassN/A

Develop Information

Active CompaniesPharming Group Nv
Inactive CompaniesGenzyme General
Active IndicationsGlycogen Storage Disease Type II
Inactive IndicationsFabry DiseaseMuscular Diseases

Other Information

ATC CodeN/A
Related LinksN/A